Boundless Bio

Boundless Bio is a clinical stage precision oncology company based in La Jolla, CA, dedicated to delivering innovative therapies for patients with intractable oncogene amplified cancers. Their groundbreaking science focuses on targeting extrachromosomal DNA (ecDNA), a key enabling mechanism in cancer, and turning it into a vulnerability, offering new hope for the millions of cancer patients worldwide who lack effective treatment options.

As the leader in the field of ecDNA, Boundless Bio is the only company solely focused on treating oncogene amplified cancers. Their comprehensive approach allows them to identify and exploit the unique vulnerabilities of ecDNA in cancer cells, developing powerful new cancer medicines that disrupt the cancer cells' ability to survive. With boundless innovation and energy, their team of professional drug hunters is at the forefront of driving the discovery and development of a novel therapeutic approach to targeting oncogene amplified cancers.

Generated from the website